Results 141 to 150 of about 13,217 (287)
Bisphosphonate-Related Osteonecrosis of the Jaw
, 2017 Introduction: Bisphosphonates are efficiently used to treat osteoporosis, bone metastases of malignant tumors, Paget`s disease and multiple myeloma. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) represents a severe side effect, consisting of ...
Kolarov, Rossen +3 more
core +1 more source
Denosumab-associated osteonecrosis of the jaw – a case report
, 2014 Osteonecrosis of the jaw (ONJ) following bisphosphonate use is well documented. However, to our knowledge, there are few cases reported on ONJ related to the use of other pharmaceutical agents, such as denosumab – a monoclonal antibody that is ...
Sabina Hameed +2 more
core +1 more source
Anterolateral‐Thigh Fascia Lata Free Flap Versus Fibula Free Flap for Mandibular Osteoradionecrosis
The Laryngoscope, Volume 136, Issue 6, Page 2565-2572, June 2026.The anterolateral thigh fascia lata “rescue” free flap has been employed as a novel tool in the treatment of advanced partial thickness mandibular osteoradionecrosis. Compared with the traditional fibula free flap for the same indication, the “rescue” flap provides similar outcomes in terms of disease resolution, superior functional outcomes, and ...
Conrad K. Blunck +8 more
wiley +1 more source
Implications in dental treatment during the use of antiresorptive drugs - a literature review
Journal of Education, Health and SportIntroduction: Antiresorptive drugs such as bisphosphonates and denosumab are crucial for treating osteoporosis, metastatic bone disease, and hypercalcemia by inhibiting osteoclast function.
Aleksandra Dziewulska +9 more
doaj +1 more source
Gerodontology, Volume 43, Issue 2, Page 198-210, June 2026.ABSTRACT Objective To explore the perceptions and practices of women in peri/menopause towards oral healthcare in Australia. Background Hormonal changes associated with peri/menopause create a period where women may be more prone to developing oral health problems, which can significantly impact their quality of life.
Namitha Thomas +4 more
wiley +1 more source
Medication-related osteonecrosis of the jaw
, 2015 In 2014, the nomenclature of bisphosphonate-related osteonecrosis of the jaw (BRONJ) was changed in medication-related osteonecrosis of the jaw (MRONJ) to include osteonecrosis of the jaw caused by non-bisphosphonates (BPs) drugs.
Pompa, Giorgio +5 more
core
Journal of the ASEAN Federation of Endocrine Societies, 2018 Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) are rare potential adverse effects of bisphosphonates and RANKL antibody therapy. The pathogenic mechanisms of both conditions are known to be independent of each other.
Edelissa Payumo +2 more
doaj
Frontiers in Oral HealthMedication-Related Osteonecrosis of the Jaw (MRONJ) is a challenging and evolving aspect of Oral and Maxillofacial Surgery. In recent years, several medications apart from those traditionally associated with MRONJ such as bisphosphates (BPs) and ...
Derek Oryniak +3 more
doaj +1 more source
Bisphosphonates and osteonecrosis of the jaw [PDF]
Rheumatology, 2007 N G, Shenker, A S M, Jawad
openaire +2 more sources